Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 18, 2026.

Severe strongyloidiasis: a systematic review of case reports

Dora Buonfrate, Ana Requena-Mendez, Andrea Angheben and 4 more

BMC Infectious Diseases · 2013 · Systematic review

doi:10.1186/1471-2334-13-78

Abstract

Background. Strongyloidiasis is commonly a clinically unapparent, chronic infection, but immuno suppressed subjects can develop fatal disease. We carried out a review of literature on hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), in order to describe the most challenging aspects of severe strongyloidiasis.

Methods. We conducted a structured search using PubMed to collect case reports and short case series on HS/DS published from 1991 to 2011. We restricted search to papers in English, Spanish, Italian and French. Case reports were classified as HS/DS according to given definitions.

Results. Records screened were 821, and 311 were excluded through titles and abstract evaluation. Of 510 full-text articles assessed for eligibility, 213 were included in qualitative analysis. As some of them were short case series, eventually the number of cases analyzed was 244. Steroids represented the main trigger predisposing to HS and DS (67% cases): they were mostly administered to treat underlying conditions (e.g. lymphomas, rheumatic diseases). However, sometimes steroids were empirically prescribed to treat signs and symptoms caused by unsuspected/unrecognized strongyloidiasis. Diagnosis was obtained by microscopy examination in 100% cases, while serology was done in a few cases (6.5%). Only in 3/29 cases of solid organ/bone marrow transplantation there is mention of pre-transplant serological screening. Therapeutic regimens were different in terms of drugs selection and combination, administration route and duration. Similar fatality rate was observed between patients with DS (68.5%) and HS (60%).

Conclusions. Proper screening (which must include serology) is mandatory in high - risk patients, for instance candidates to immunosuppressive medications, currently or previously living in endemic countries. In some cases, presumptive treatment might be justified. Ivermectin is the gold standard for treatment, although the optimal dosage is not clearly defined in case of HS/DS.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

Background

Strongyloidiasis is a neglected condition caused by Strongyloides stercoralis, a soil – transmitted helminth mainly diffused in tropical and subtropical regions, but also present in small areas of low endemicity in temperate climates. Most infected individuals are asymptomatic or may present intermittent symptoms, mostly affecting intestine (from mild abdominal pain, intermittent or persistent diarrhea to more severe conditions that can mimic inflammatory bowel disease), lungs (cough, wheezing and asthma, chronic bronchitis) and skin (pruritus, rash). Systemic symptoms such as weight loss and cachexia may also occur. Immune suppressed subjects tend to develop hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), that are potentially fatal. Therefore, it is mandatory to diagnose and treat the chronic infection, in order to prevent the life-threatening form. Unfortunately, the index of suspicion of health care providers seems to be low, especially in non-endemic countries. Moreover, there are still gaps in knowledge regarding many aspects of the infection, such as diagnosis and treatment response.

Our aim was to systematically review case reports of severe strongyloidiasis, in order to outline the main features of hyperinfection and disseminated strongyloidiasis and the difficulties in their management.

Methods

We carried out a systematic review of case reports/short case series published in PubMed from January 1991 to April 2011. We considered papers available in the following languages: English, Spanish, Italian, French.

The electronic search strategy was as follows: disease (strongyl*, anguillulose) AND severity of cases (disseminat*, hyperinfect*, severe, death, fatal, mortality) OR disease (strongyl*, anguillulose) AND associated conditions (tumor*, cancer, haematolog*, lymphom*, leukem*, leukaem*, neoplas*, malignan*, HTLV*, HIV, AIDS, hypogammaglobulinemia, rheumat*, “biological agents”, diabet*, transplant*, COPD, steroid*, glucocorticoid*, Immunosuppression [MeSH], Immunocompromised Host [MeSH]) and limiting the search to humans. Search was done on March 20th 2011.

Definitions used for case - inclusion: - Dissemination: larvae found in any organ, other than the respiratory and the gastrointestinal tracts. Hyperinfection: infection confined to lungs and gastrointestinal tract, but signs/symptoms of severe diseases in relation to elevated number of larvae; in particular, necessity of intensive care, presence of sepsis/meningitis by enteric bacteria, death (without any other clear underlying cause).

Data synthesis

Our search strategy permitted to identify 821 papers, of which 311 were excluded by title and abstract evaluation. Full-text papers were then assessed for eligibility according to the criteria outlined above. Among the 213 papers included, some were small case series, eventually the number of cases analyzed was 244 (Figure 1).

Countries

Reports from highly endemic countries were 65/244 (27%), with India (), Argentina (), Brazil () and Peru () accounting for more than two thirds. Only four cases were reported from the whole of Africa, three of which in South Africa, a state where adequate diagnostic facilities are available. We collected 83/244 (34%) reports from North America (USA and Canada), 58/244 (24%) from Europe (Belgium, France, Germany, Greece, Italy, the Netherlands, Spain, Switzerland, UK) and five (2%) from Oceania (Australia and New Zealand). In these areas of low/no endemicity, half of the patients were immigrants (70/146, 48%), while a few subjects were veterans (5/146, 3%) who presumably acquired the infection during military service in an endemic country. Other areas of low endemicity where cases have been reported are in Eastern Asia (21 cases, mostly from Japan () and Taiwan ()), the Arabian peninsula (nine cases, mostly from Kuwait () and Qatar ()) and Israel () (three cases). Countries such as Iran (), Turkey () and Venezuela () that might be presumed at medium to high prevalence, account for only one case each.

Triggers for development of HS/DS

According to the case definitions, 171 cases were classified as hyper infection and 73 cases as dissemination.

A high percentage of patients (67%: 164/244) were under corticosteroids: most of them presented clinical conditions causing immune suppression per-se or due to other related therapies (for instance leukemia, rheumatic conditions, transplant), as it is shown in Table 1. On the other hand, a few patients were taking steroids for eosinophilia and/or a specific symptoms caused by S. stercoralis itself (data reported in Table 1 too). A patient even underwent bone marrow transplant because of an unexplained eosinophilia misdiagnosed as “idiopathic hypereosinophilic syndrome”; after receiving steroids and immunosuppressive therapy he developed HS (but only limited autopsy was performed, so we cannot rule out DS) and died.

Transplant is surely an event that poses the Strongyloides - infected patient at high risk of developing HS/DS. We collected 28/244 (11.5%) cases of HS/DS in transplant patients, of whom 19 (68%) died. A couple of patients who developed hyper infection also had co infection with CMV. All the surviving patients received ivermectin, either as single treatment (1 patient) or in combination with albendazole (7) or thiabendazole (1).

HTLV-1 infection is a well known risk factor (sometimes in association with related haematological malignancies), of which we found 24/244 (10%) reports (). Ten of the 24 patients (42%) died. One patient had HTLV-1-HIV co infection; he developed an E. coli meningitis but successfully responded to ivermectin, two doses given some days (not specified how many) apart.

We found 38/244 (15%) reports on HIV-positive patients, 26 (68%) of whom died (Figure 2). Seven HIV patients were also receiving steroids for suspected Pneumocystis jiroveci pneumonia, immune reconstitution inflammatory syndrome, misdiagnosis of asthma, Wegener granulomatosis, toxoplasmosis encephalitis, cerebral TB with vasculitis; six of them died.

A few reports/case series describe severe strongyloidiasis in patients with alcoholism and malnutrition. An apparently immunocompetent patient developed hyper infection and died two days after having started therapy with thiabendazole. Unfortunately autopsy was denied.

Diagnosis

Eosinophilia was present in 55/244 cases (22.5%) overall, and only in 12/73 cases (16.4%) of dissemination. In all cases S. stercoralis was found at microscopy examination of biological samples. Serology was performed only in 16/244 patients (6.5%) (Table 2). In a couple of organ transplant recipients, an ELISA test was negative pre-transplant, but resulted positive in the deceased donors (test performed retrospectively). In other two cases serology (ELISA) was negative: a HIV-infected person, who had larvae in stool and sputum and a patient with dermatomyositis, under chronic treatment with prednisone and methotrexate, who died from disseminated strongyloidiasis (larvae found at autopsy in skin, lungs, small and large bowel, gall bladder, vessels of meninges and cervical spinal cord).

Diagnosis was obtained post mortem in 29 cases (12%).

Therapy

Therapies given were very different in relation to the drugs used and the length of treatment.

In Table 3 we summarize the drugs used. In the “other drugs” group we found mebendazole, cambendazole, levamisole, pyrantel pamoate, diethylcarbamazine.

Albendazole was used as a single drug even in recent case reports; since 2008 we found patients treated with albendazole only in reports from Pakistan, Romania, Taiwan, Israel, Kuwait, Argentina, Malaysia, Greece, Thailand.

In most cases the administration route was oral, but due to severe clinical conditions of patients, administration via nasogastric tube, subcutaneous injection (veterinary formulation) and retention enema were used, too.

A patient who developed disseminated strongyloidiasis after an empiric steroid treatment for pruritic rash was treated with albendazole. Only one dose could be given, as the patient died. After his death, a review of his clinical records showed that he had been previously diagnosed with strongyloidiasis and treated with a 3-day course of albendazole; although serology persisted positive and eosinophilia was still present 6 and 12 months after treatment, the patient did not receive any further therapy. Another patient who died from Strongyloides hyper infection had never been treated previously, despite a positive serology.

Outcome

The recorded deaths were 153/244 (62.7%). A similar fatality rate was observed in patients with dissemination (50/73 = 68.5%) and with hyperinfection (102/171 = 60%).

All 42 of 244 patients who did not receive any therapy died. Excluding patients treated with combination therapy, we observe that 25/34 (73%) patients treated with albendazole died, while deaths among patients treated with ivermectin and thiabendazole were 18/38 (47%) and 28/55 (51%), respectively.

Discussion

Considering that a considerable number of case reports are described in non endemic countries, we assume that fatal cases must be quite frequent in endemic countries, although they are not frequently published in the literature.

The main risk factors identified in this review have been reported previously, in particular steroids are frequently the trigger for developing severe strongyloidiasis. Unfortunately it was not possible to extract from the case reports the cumulative dosage and the duration of the corticosteroids treatment. Although the association with steroids should be well known, there are still papers reporting cases of patients under steroids who had not been previously screened for strongyloidiasis. Moreover, we found papers reporting severe strongyloidiasis in patients who were previously diagnosed with the infection but had not received a proper treatment. Once more, the lack of familiarity with strongyloidiasis by health care providers is the weak link in the chain; this is also highlighted by the fact that in 12% of cases the diagnosis was made post mortem. Eosinophil count is often normal in severe strongyloidiasis, hence this test has a limited excluding power.

Serology was not frequently performed. In fact, in case of hyperinfection and dissemination the diagnosis is easily made by direct examination of the biological samples. Serology would be most useful in chronic infections, before hyperinfection and/or dissemination occur, while in patients who are already immune suppressed its sensitivity is probably lower.

Limits in our results are due to incomplete information in the case descriptions. Moreover, cases in which autopsy was not performed sometimes couldn’t allow a proper classification. Actually, in the 65 cases we classified as hyper infections, autopsy was not done, hence it is not possible to rule out dissemination. Moreover, we found the same fatality rate for patients with hyper infection and with dissemination, but a misclassification might have played a role. In fact, we think that from a clinical, practical point of view the distinction between hyper infection and dissemination is not essential, because they’re both severe conditions requiring immediate assessment and care.

In general, the best drug to treat strongyloidiasis is ivermectin which is effective and well tolerated. There are still some concerns about the treatment schedule of the chronic infection, and this is even more debated in case of hyper infection/dissemination. In fact there are no specific guidelines and the case reports we collected outline a Babylon of different therapeutic schemes. Subcutaneous ivermectin (veterinary formulation) has been used on an empiric basis, when intestinal absorption is decreased or the patient cannot swallow tablets. On the other hand, albendazole is still used even as a single drug, although it has been proved to be poorly effective. In some cases, this might be due to the scarce availability of ivermectin in many countries.

Conclusions

The first step to be done to guarantee an adequate management of infected patients is to avoid a delayed diagnosis. Unfortunately, lack of familiarity with strongyloidiasis by health care providers still seems to be the main cause of delay. A better diffusion of the available information is badly needed, and collaboration among different specialists (oncologists, rheumatologists…) is desirable in order to provide common and adequate protocols for screening and treatment of at – risk patients.

It is mandatory to treat patients in the chronic phase, before HS/DS develop. Patients with possible, previous exposure to the parasite should be screened with serology before corticosteroid treatment, chemotherapy or transplant. Considering the high tolerability of ivermectin, it would be probably worth treating high – risk patients irrespective of the result of the screening test, in order to avoid the potential consequences of a possible false negative result.

Ivermectin is currently the gold standard for treatment of strongyloidiasis, so it is simply no more ethical to use any other drug. Moreover, ivermectin is in the WHO model lists of essential medicines, so it should be registered and made available everywhere, particularly in endemic countries.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

DB searched PubMed, analyzed the data and wrote the manuscript. ARM analyzed the data and critically reviewed the manuscript. AA created the search strategy and analyzed the data. JM, FG and JVDE gave intellectual content and critically reviewed the manuscript. ZB conceptualized the review and critically reviewed the manuscript. All authors read and approved the final manuscript.

Authors’ information

Cohemi project study group: Maurizio Bonati, Francesca Severino, Valeria Confalonieri, Chiara Pandolfini, Zeno Bisoffi, Dora Buonfrate, Andrea Angheben, Marco Albonico, Alessandro Bartoloni, Marianne Strohmeyer, Lorenzo Zammarchi, Jose Muñoz, Robert Pool, Ana Requena-Mendez, Maria Roura, Anita Hardon, Christopher Pell, Peter Chiodini, Juan Moreira, Roberto Sempértegui, Mariella Anselmi, Eduardo Gotuzzo, Maria Alejandra Mena, Hector H. Garcia, Javier Bustos, Saul Santiva, Faustino Torrico,Daniel Lozano, Guido Chumiray Rojas, Teresa Hinojosa Cabrera, Javier Ochoa Morón, Ignacio Abapori Cuellar, Jaime Amorós Suarez, Gianni Tognoni, Alessandra Nicoletti, Elisa Bruno

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/13/78/prepub

References 219

  1. 1.

    WHOStrongyloidiasishttp://www.who.int/neglected_diseases/diseases/strongyloidiasis/en/

    Not in our library

  2. 2.

    Olsen A Van Lieshout L Marti H Polderman T Polman K Steinmann P Stothard R Thybo S Verweij JJ Magnussen P Strongyloidiasis–the most neglected of the neglected tropical diseases?Trans R Soc Trop Med Hyg2009 10310967972

    Not in our library10.1016/j.trstmh.2009.02.013

  3. 3.

    Marcos LA Terashima A Canales M Gotuzzo E Update on Strongyloidiasis in the immunocompromised hostCurr Infect Dis Rep2011 133546

    Not in our library10.1007/s11908-010-0150-z

  4. 4.

    Boulware DR Stauffer WM Hendel-Paterson BR Rocha JL Seet RC Summer AP Nield LS Supparatpinyo K Chaiwarith R Walker PF Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training surveyAm J Med2007 1206545e541-548

    Not in our library10.1016/j.amjmed.2006.05.072

  5. 5.

    Keiser PB Nutman TB Strongyloides stercoralis in the immunocompromised populationClin Microbiol Rev2004 171208217

    Not in our library10.1128/cmr.17.1.208-217.2004

  6. 6.

    Agrawal V Agarwal T Ghoshal UC Intestinal strongyloidiasis: a diagnosis frequently missed in the tropicsTrans R Soc Trop Med Hyg2009 1033242246

    Not in our library10.1016/j.trstmh.2008.08.009

  7. 7.

    Ghosh K Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three casesT Roy Soc Trop Med H2007 1011111631165

    Not in our library10.1016/j.trstmh.2007.05.021

  8. 8.

    Das P Raghu P Amit Kumar D Garg P Strongyloides hyperinfection in rheumatoid arthritisInt J Surg Pathol2007 154391392

    Not in our library10.1177/1066896907302241

  9. 9.

    Ghoshal UC Saha J Ghoshal U Ray BK Santra A Naik S Mazumder DN Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observationsJ Diarrhoeal Dis Res1999 1714345

    Not in our library

  10. 10.

    Ghoshal UC Ghoshal U Jain M Kumar A Aggarwal R Misra A Ayyagari A Naik SR Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteriaJ Gastroenterol Hepatol2002 171213311333

    Not in our library10.1046/j.1440-1746.2002.02750.x

  11. 11.

    Ghoshal UC Alexender G Ghoshal U Tripathi S Krishnani N Strongyloides stercoralis infestation in a patient with severe ulcerative colitisIndian J Med Sci2006 603106110

    Not in our library10.4103/0019-5359.22761

  12. 12.

    Jeyamani R Joseph AJ Chacko A Severe and treatment resistant strongyloidiasis–indicator of HTLV-I infectionTrop Gastroenterol2007 284176177

    Not in our library

  13. 13.

    Murali A Rajendiran G Ranganathan K Shanthakumari S Disseminated infection with Strongyloides stercoralis in a diabetic patientIndian J Med Microbiol2010 284407408

    Not in our library10.4103/0255-0857.71854

  14. 14.

    Patil PL Salkar HR Ghodeswar SS Gawande JP Parasites (filaria & strongyloides) in malignant pleural effusionIndian J Med Sci2005 5910455456

    Not in our library10.4103/0019-5359.17053

  15. 15.

    Premanand R Prasad GV Mohan A Gururajkumar A Reddy MK Eosinophilic pleural effusion and presence of filariform larva of Strongyloides stercoralis in a patient with metastatic squamous cell carcinoma deposits in the pleuraIndian J Chest Dis Allied Sci2003 452121124

    Not in our library

  16. 16.

    Rajapurkar M Hegde U Rokhade M Gang S Gohel K Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failureNat Clin Pract Nephrol2007 310573577

    Not in our library10.1038/ncpneph0598

  17. 17.

    Reddy IS Swarnalata G Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two casesIndian J Dermatol Venereol Leprol2005 7113840

    Not in our library10.4103/0378-6323.13785

  18. 18.

    Sathe PA Madiwale CV Strongyloidiasis hyperinfection in a patient with membranoproliferative glomerulonephritisJ Postgrad Med2006 523221222

    Not in our library

  19. 19.

    Satyanarayana S Nema S Kalghatgi AT Mehta SR Rai R Duggal R Bhardwaj JR Disseminated Strongyloides stercoralis in AIDS: a report from IndiaIndian J Pathol Microbiol2005 484472474

    Not in our library

  20. 20.

    Sekhar U Madan M Ranjitham M Abraham G Eapen G Strongyloides hyperinfection syndrome–an unappreciated opportunistic infectionJ Assoc Physicians India2000 481010171019

    Not in our library

  21. 21.

    Soman R Vaideeswar P Shah H Almeida AF A 34-year-old renal transplant recipient with high-grade fever and progressive shortness of breathJ Postgrad Med2002 483191196

    Not in our library

  22. 22.

    Sreenivas DV Kumar A Kumar YR Bharavi C Sundaram C Gayathri K Intestinal strongyloidiasis–a rare opportunistic infectionIndian J Gastroenterol: J Indian Soc Gastroenterol1997 163105106

    Not in our library

  23. 23.

    Vigg A Mantri S Reddy VA Biyani V Acute respiratory distress syndrome due to Strongyloides stercoralis in non-Hodgkin’s lymphomaIndian J Chest Dis Allied Sci2006 4816769

    Not in our library

  24. 24.

    Bava AJ Troncoso AR Strongyloides stercoralis hyperinfection in a patient with AIDSJ Int Assoc Physicians AIDS Care (Chic)2009 84235238

    Not in our library10.1177/1545109709336882

  25. 25.

    Galimberti R Ponton A Zaputovich FA Velasquez L Galimberti G Torre A Kowalczuk A Disseminated strongyloidiasis in immunocompromised patients–report of three casesInt J Dermatol2009 489975978

    Not in our library10.1111/j.1365-4632.2009.04082.x

  26. 26.

    Rivero FD Kremer LE Allende L Casero RD [Strongyloides stercoralis and HIV: a case report of an indigenous disseminated infection from non-endemic area]Rev Argent Microbiol2006 383137139

    Not in our library

  27. 27.

    Taranto NJ [Strongyloides stercoralis. Report of a case and review of the literature]Acta Gastroenterol Latinoam1995 252113120

    Not in our library

  28. 28.

    Trione N Corti M Castello T Abuin JC Bellegarde E [Disseminated infection due to strongyloides stercoralis in AIDS patients. A report of 2 cases]Acta Gastroenterol Latinoam2001 315399402

    Not in our library

  29. 29.

    Dulley FL Costa S Cosentino R Gamba C Saboya R Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantationBone Marrow Transplant2009 439741742

    Not in our library10.1038/bmt.2008.383

  30. 30.

    Salluh JI Feres GA Velasco E Holanda GS Toscano L Soares M Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shockIntensive Care Med2005 3191292

    Not in our library10.1007/s00134-005-2725-y

  31. 31.

    German JC Flores JH Chiesura G Ruiz EM Flores SS Laudanna AA [Fatal strongyloidiasis in an immunodepressed patient following renal transplantation]Revista do Hospital das Clinicas1992 4713133

    Not in our library

  32. 32.

    Lambertucci JR Leao FC Barbosa AJ Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1)Rev Soc Bras Med Trop2003 364541542

    Not in our library10.1590/s0037-86822003000400021

  33. 33.

    Lambertucci JR Westin MR Barbosa AJ Severe gastrointestinal strongyloidiasisRev Soc Bras Med Trop2005 384365366

    Not in our library10.1590/s0037-86822005000400023

  34. 34.

    Rodrigues MA Froes RC Anefalos A Kobayasi S Invasive enteritis by Strongyloides stercoralis presenting as acute abdominal distress under corticosteroid therapyRevista do Hospital das Clinicas2001 564103106

    Not in our library10.1590/s0041-87812001000400002

  35. 35.

    Porto MA Alcantara LM Leal M Castro N Carvalho EM Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type IAm J Trop Med H2005 722124125

    Not in our library

  36. 36.

    Siciliano RF Mascheretti M Ho YL Gryschek RC Severe strongyloidiasis in AIDS: is steroid therapy guilty again?J Acquir Immune Defic Syndr2008 493333334

    Not in our library10.1097/qai.0b013e31817bedde

  37. 37.

    Tabacof J Feher O Katz A Simon SD Gansl RC Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsisCancer1991 68818211823

    Not in our library10.1002/1097-0142(19911015)68:8<1821::aid-cncr2820680829>3.0.co;2-j

  38. 38.

    Takayanagui OM Lofrano MM Araugo MB Chimelli L Detection of Strongyloides stercoralis in the cerebrospinal fluid of a patient with acquired immunodeficiency syndromeNeurology1995 451193194

    Not in our library10.1212/wnl.45.1.193

  39. 39.

    Vilela EG Clemente WT Mira RR Torres HO Veloso LF Fonseca LP De Carvalho EFLR Franca MC Lima AS Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature reviewTransplant Inf Dis: J Transplant Soc2009 112132136

    Not in our library10.1111/j.1399-3062.2008.00350.x

  40. 40.

    De Goede E Martens M Van Rooy S VanMoerkerke I A case of systemic strongyloidiasis in an ex-coal miner with idiopathic colitisEuropean J Gastroenterol Hepatol1995 78807809

    Not in our library

  41. 41.

    Mora CS Segami MI Hidalgo JA Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndromeSemin Arthritis Rheu2006 363135143

    Not in our library10.1016/j.semarthrit.2006.06.001

  42. 42.

    Zavala J Sanchez L Carillo L Cueva A Balbin G Quispe V [Atypical presentations of strongyloidiasis: a report of 8 cases]Rev Gastroenterol Peru1994 1411521

    Not in our library

  43. 43.

    Adetiloye VA A case of fatal gastrointestinal strongyloidiasis in an otherwise healthy Nigerian, masquerading as gastric outlet obstructionTrop Geogr Med1992 441–26062

    Not in our library

  44. 44.

    Coovadia YM Rajput MC Bhana RH Disseminated strongyloidiasis in a diabetic patientTrop Geogr Med1993 454179180

    Not in our library

  45. 45.

    Daubenton JD Buys HA Hartley PS Disseminated strongyloidiasis in a child with lymphoblastic lymphomaJ Pediatr Hematol Oncol: Am Soc Pediatr Hematol Oncol1998 203260263

    Not in our library10.1097/00043426-199805000-00014

  46. 46.

    Haddow LJ Mahlakwane MS Ramdial PK Moosa MY Histopathology of Strongyloides stercoralis hyperinfection during immune reconstitution in an HIV-infected patientAIDS2009 231216091611

    Not in our library10.1097/qad.0b013e32832c41f4

  47. 47.

    Jamil SA Hilton E The Strongyloides hyperinfection syndromeNew York State J1992 9226768

    Not in our library

  48. 48.

    Purvis RS Beightler EL Diven DG Sanchez RL Tyring SK Strongyloides hyperinfection presenting with petechiae and purpuraNt J Dermatol1992 313169171

    Not in our library10.1111/j.1365-4362.1992.tb03925.x

  49. 49.

    Boken DJ Leoni PA Preheim LC Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectumClin Infect Dis: Infect Dis Soc Am1993 161123126

    Not in our library10.1093/clinids/16.1.123

  50. 50.

    Celedon JC Mathur-Wagh U Fox J Garcia R Wiest PM Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literatureMedicine1994 735256263

    Not in our library10.1097/00005792-199409000-00004

  51. 51.

    El Masry HZ O’Donnell J Fatal stongyloides hyperinfection in heart transplantationJ Heart Lung Transpl: Int Soc Heart Transpl2005 241119801983

    Not in our library10.1016/j.healun.2005.04.005

  52. 52.

    Foreman EB Abraham PJ Garland JL Not your typical strongyloides infection: a literature review and case studySouth Med J2006 998847852

    Not in our library10.1097/01.smj.0000203813.70054.3c

  53. 53.

    Friedenberg F Wongpraparut N Fischer RA Gubernick J Zaeri N Eiger G Ozden Z Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected hostDigest Dis Sci1999 44611841188

    Not in our library10.1023/a:1026636509713

  54. 54.

    Fusco DN Downs JA Satlin MJ Pahuja M Ramos L Barie PS Fleckenstein L Murray HW Non-oral treatment with ivermectin for disseminated strongyloidiasisAm J Trop Med Hyg2010 834879883

    Not in our library10.4269/ajtmh.2010.10-0258

  55. 55.

    Nomura J Rekrut K Strongyloides stercoralis hyperinfection syndrome in a patient with AIDS: diagnosis by fluorescent microscopyClin inf dis: Inf Dis Soc Am1996 224736

    Not in our library10.1093/clinids/22.4.736

  56. 56.

    Goldman DE Grier JF Ball BE Abreo F Abreo KD A 72-year-old woman with non-Hodgkin’s lymphoma, dyspnea, vomiting, diarrhea, and eosinophiliaJ La State Med Soc: Louisiana State Med Soc1995 1476243250

    Not in our library

  57. 57.

    Gordon SM Gal AA Solomon AR Bryan JA Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised hostJ Am Acad Dermatol1994 312 Pt 1255259

    Not in our library10.1016/s0190-9622(94)70158-x

  58. 58.

    Gulick RM Reappearance of a remotely acquired infectionAIDS Clin Care1997 9970

    Not in our library

  59. 59.

    Gutierrez Y Bhatia P Garbadawala ST Dobson JR Wallace TM Carey TE Strongyloides stercoralis eosinophilic granulomatous enterocolitisAm J Surg Pathol1996 205603612

    Not in our library10.1097/00000478-199605000-00007

  60. 60.

    Hamilton KW Abt PL Rosenbach MA Bleicher MB Levine MS Mehta J Montgomery SP Hasz RD Bono BR Tetzlaff MT Donor-derived Strongyloides stercoralis infections in renal transplant recipientsTransplantation2011 91910191024

    Not in our library10.1097/tp.0b013e3182115b7b

  61. 61.

    Hong IS Zaidi SY McEvoy P Neafie RC Diagnosis of Strongyloides stercoralis in a peritoneal effusion from an HIV-seropositive man. A case reportActa Cytol2004 482211214

    Not in our library10.1159/000326318

  62. 62.

    Jain AK Agarwal SK El-Sadr W Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virusCli inf dis: Inf Dis Soc Am1994 182253254

    Not in our library10.1093/clinids/18.2.253

  63. 63.

    Kao D Murakawa GJ Kerschmann R Berger T Disseminated strongyloidiasis in a patient with acquired immunodeficiency syndromeArch Dermatol1996 1328977978

    Not in our library10.1001/archderm.1996.03890320127027

  64. 64.

    Kothary NN Muskie JM Mathur SC Strongyloides stercoralis hyperinfectionRadiographics: Radiological SocNorth Am Inc1999 19410771081

    Not in our library10.1148/radiographics.19.4.g99jl171077

  65. 65.

    Lambroza A Dannenberg AJ Eosinophilic ascites due to hyperinfection with Strongyloides stercoralisAm J Gastroenterol1991 8618991

    Not in our library

  66. 66.

    Lemos LB Qu Z Laucirica R Fred HL Hyperinfection syndrome in strongyloidiasis: report of two casesAnn Diagn Pathol2003 728794

    Not in our library10.1053/adpa.2003.50019

  67. 67.

    Lin AL Kessimian N Benditt JO Restrictive pulmonary disease due to interlobular septal fibrosis associated with disseminated infection by Strongyloides stercoralisAm J Respir Crit Care Med1995 1511205209

    Not in our library10.1164/ajrccm.151.1.7812554

  68. 68.

    Link K Orenstein R Bacterial complications of strongyloidiasis: Streptococcus bovis meningitisSouth Med J1999 927728731

    Not in our library10.1097/00007611-199907000-00016

  69. 69.

    Malhotra A Kochar T Rangasetty UC A perfect hostIntern Med J2008 3811869870

    Not in our library10.1111/j.1445-5994.2008.01782.x

  70. 70.

    Schaeffer MW Buell JF Gupta M Conway GD Akhter SA Wagoner LE Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literatureJ Heart Lung Transpl: Int Soc Heart Transpl2004 237905911

    Not in our library10.1016/j.healun.2003.06.008

  71. 71.

    Tarr PE Miele PS Peregoy KS Smith MA Neva FA Lucey DR Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndromeAm J Trop Med Hyg2003 684453455

    Not in our library

  72. 72.

    Marty FM Lowry CM Rodriguez M Milner DA Pieciak WS Sinha A Fleckenstein L Baden LR Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectinClin Inf Dis: Inf Dis Soc Am2005 411e5e8

    Not in our library10.1086/430827

  73. 73.

    Miller MA Church LW Salgado CD Strongyloides hyperinfection: a treatment dilemmaAm J Med Sci2008 3364358361

    Not in our library10.1097/maj.0b013e31815cff89

  74. 74.

    Mizuno S Iida T Zendejas I Martin TD Schain DC Turner B Fujita S Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantationTransplant Int: J European Soc Organ Transplant2009 222251253

    Not in our library10.1111/j.1432-2277.2008.00767.x

  75. 75.

    Morgello S Soifer FM Lin CS Wolfe DE Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literatureActa Neuropathol1993 863285288

    Not in our library10.1007/bf00304143

  76. 76.

    Morrell MR Dallas J Kollef MH A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantationChest2008 1342442446

    Not in our library10.1378/chest.07-2754

  77. 77.

    Newton RC Limpuangthip P Greenberg S Gam A Neva FA Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppressionAm J Med1992 922202208

    Not in our library10.1016/0002-9343(92)90113-p

  78. 78.

    Gupta S Jain A Fanning TV Couriel DR Jimenez CA Eapen GA An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case reportBMC Cancer2006 687

    Not in our library10.1186/1471-2407-6-87

  79. 79.

    Perazella MA Sadigh M Acute nonspecific illness in an AIDS patients with dysphagiaHosp Pract (Off Ed)1994 29113943, 47

    Not in our library10.1080/21548331.1994.11443104

  80. 80.

    Phelps KR Ginsberg SS Cunningham AW Tschachler E Dosik H Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfectionAm J Med Sci1991 3024224228

    Not in our library10.1097/00000441-199110000-00006

  81. 81.

    Qazilbash MH Ueno NT Hosing C De Lima M Cortes J Massaro A Rivera Z Deavers M Adachi JA Champlin RE Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantationBone Marrow Transplant2006 385393394

    Not in our library10.1038/sj.bmt.1705448

  82. 82.

    Purvis RS Beightler EL Diven DG Sanchez RL Tyring SK Strongyloides stercoralis hyperinfectionInt J Dermatol1992 313160164

    Not in our library10.1111/j.1365-4362.1992.tb03918.x

  83. 83.

    Krishnamurthy R Dincer HE Whittemore D Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapyJ Clin Rheumatology: Rheumatic & musculoskeletal dis2007 133150152

    Not in our library10.1097/rhu.0b013e3180690933

  84. 84.

    Reddy TS Myers JW Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfectionAm Journal Med Sci2003 3255288291

    Not in our library10.1097/00000441-200305000-00007

  85. 85.

    Gorman SR Craven DE Images in clinical medicine. Strongyloides stercoralis hyperinfectionNew England J Med2008 35911e12

    Not in our library10.1056/nejmicm066791

  86. 86.

    Reiman S Fisher R Dodds C Trinh C Laucirica R Whigham CJ Mesenteric arteriographic findings in a patient with strongyloides stercoralis hyperinfectionJVIR2002 136635638

    Not in our library10.1016/s1051-0443(07)61660-1

  87. 87.

    Roxby AC Gottlieb GS Limaye AP Strongyloidiasis in transplant patientsClin Inf Dis: Inf Dis So Am2009 49914111423

    Not in our library10.1086/630201

  88. 88.

    Patel G Arvelakis A Sauter BV Gondolesi GE Caplivski D Huprikar S Strongyloides hyperinfection syndrome after intestinal transplantationTranspl inf Dis: J Transplant Soc2008 102137141

    Not in our library10.1111/j.1399-3062.2007.00256.x

  89. 89.

    Schindzielorz A Edberg SC Bia FJ Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritisSouthern Med J1991 84810551057

    Not in our library10.1097/00007611-199108000-00030

  90. 90.

    Lichtenberger P Rosa-Cunha I Morris M Nishida S Akpinar E Gaitan J Tzakis A Doblecki-Lewis S Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectinTransplant Inf Disease: J Transplant SocS2009 112137142

    Not in our library10.1111/j.1399-3062.2008.00358.x

  91. 91.

    Agarwal VK Khurana HS Le HX Mathisen G Kamangar N 30-year-old HIV-positive female with diffuse alveolar hemorrhageJ Int Care Med2009 243200204

    Not in our library10.1177/0885066609332583

  92. 92.

    Balagopal A Mills L Shah A Subramanian A Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantationTransplant Inf Dis: J Transplant Soc2009 112149154

    Not in our library10.1111/j.1399-3062.2009.00375.x

  93. 93.

    Simpson WG Gerhardstein DC Thompson JR Disseminated Strongyloides stercoralis infectionSouthern Med J1993 867821825

    Not in our library10.1097/00007611-199307000-00022

  94. 94.

    Huston JM Eachempati SR Rodney JR Cayci C Fusco D Mathew M Shou J Goldstein MJ Kapur S Barie PS Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipientTransplant Inf Dis: J Transplant Soc2009 113277280

    Not in our library10.1111/j.1399-3062.2009.00386.x

  95. 95.

    Khasawneh F Sreedhar R Chundi V Strongyloides hyperinfection: an unusual cause of respiratory failureAnn Intern Med2009 1508570571

    Not in our library10.7326/0003-4819-150-8-200904210-00019

  96. 96.

    Thompson JR Berger R Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasisChest1991 993772774

    Not in our library10.1378/chest.99.3.772

  97. 97.

    Aregawi D Lopez D Wick M Scheld WM Schiff D Disseminated strongyloidiasis complicating glioblastoma therapy: a case reportJ Neurooncol2009 943439443

    Not in our library10.1007/s11060-009-9878-4

  98. 98.

    Apewokin S Steciuk M Griffin S Jhala D Strongyloides hyperinfection diagnosed by bronchoalveolar lavage in an immunocompromized hostCytopathology: Journal of the British Soc Clin Cytol2010 215345347

    Not in our library10.1111/j.1365-2303.2010.00765.x

  99. 99.

    Upadhyay D Corbridge T Jain M Shah R Pulmonary hyperinfection syndrome with Strongyloides stercoralisAm J Med2001 1112167169

    Not in our library10.1016/s0002-9343(01)00708-2

  100. 100.

    Basile A Simzar S Bentow J Antelo F Shitabata P Peng SK Craft N Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppressionJ Am Acad Dermatol2010 635896902

    Not in our library10.1016/j.jaad.2009.09.037

  101. 101.

    Vadlamudi RS Van Dort M Barklow T Byrd RP Jr Moorman JP Strongyloides hyperinfection syndrome complicating (ectopic) Cushing syndromeSouthern Med J2008 1017750752

    Not in our library10.1097/smj.0b013e31817a836e

  102. 102.

    Wang BY Krishnan S Isenberg HD Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapyMount Sinai J Med New York1999 662128132

    Not in our library

  103. 103.

    Williams BT Guerry-Force ML Disseminated strongyloidiasis in a World War II Veteran with metastatic undifferentiated carcinoma of neuroendocrine typeSouthern Med J1992 851010231026

    Not in our library10.1097/00007611-199210000-00025

  104. 104.

    Wirk B Wingard JR Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantationTransplant Inf Dis: J Transplant Soc2009 112143148

    Not in our library10.1111/j.1399-3062.2008.00360.x

  105. 105.

    Grein JD Mathisen GE Donovan S Fleckenstein L Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case reportScandinavian J Inf Dis2010 423234236

    Not in our library10.3109/00365540903443165

  106. 106.

    Martin SJ Cohen PR MacFarlane DF Grossman ME Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patientSkinmed2011 93199202

    Not in our library

  107. 107.

    Weiser JA Scully BE Bulman WA Husain S Grossman ME Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplantTransplant Inf Dis: J Transplant Soc2011 1315862

    Not in our library10.1111/j.1399-3062.2010.00516.x

  108. 108.

    Lessnau KD Can S Talavera W Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literatureChest1993 1041119122

    Not in our library10.1378/chest.104.1.119

  109. 109.

    Ali HA Walkenstein M Bilateral nodular pulmonary infiltrates in an immunocompromised hostThorax2008 638746753

    Not in our library10.1136/thx.2007.090100

  110. 110.

    Hughes R McGuire G Delayed diagnosis of disseminated strongyloidiasisIntensive Care Med2001 271310312

    Not in our library10.1007/s001340000798

  111. 111.

    Lagace-Wiens PR Harding GK A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1CMAJ2007 1775451453

    Not in our library10.1503/cmaj.070126

  112. 112.

    Leung V Al-Rawahi GN Grant J Fleckenstein L Bowie W Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfectionAm J Trop Med Hyg2008 796853855

    Not in our library

  113. 113.

    Lim S Katz K Krajden S Fuksa M Keystone JS Kain KC Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and managementCMAJ2004 1715479484

    Not in our library10.1503/cmaj.1031698

  114. 114.

    Peters L McCarthy AE Faught C Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two casesIJID: Int Soc Inf Dis2009 136e501e503

    Not in our library10.1016/j.ijid.2009.02.009

  115. 115.

    Rawat B Simons ME Strongyloides stercoralis hyperinfestation. Another cause of focal hepatic lesionsClin Imaging1993 174274275

    Not in our library10.1016/0899-7071(93)90069-y

  116. 116.

    Turner SA Maclean JD Fleckenstein L Greenaway C Parenteral administration of ivermectin in a patient with disseminated strongyloidiasisAm J Trop Med Hyg2005 735911914

    Not in our library

  117. 117.

    Vandebosch S Mana F Goossens A Urbain D Strongyloides Stercoralis infection associated with repititive bacterial meningitis and SIADH: a case reportActa gastro-enterologica Belgica2008 714413417

    Not in our library

  118. 118.

    Collet F Favory R Augusto D Moukassa D Dutoit E Mathieu D [Massive haemoptysis associated with pulmonary Strongyloides stercoralis hyperinfestation]Rev Mal Respir2005 225 Pt 1815818

    Not in our library10.1016/s0761-8425(05)85640-2

  119. 119.

    Couprie R Maslo C Bouchaud O Matheron S Saimot AG Coulaud JP [Disseminated anguilluliasis in HIV infection. A new case]Presse Med1993 2220968

    Not in our library

  120. 120.

    Daoudal P Ribier G Numeric P Desbois N Ramialison C [Disseminated strongyloidiasis, a rare cause of multiple organ failure]Presse Med2002 312612161217

    Not in our library

  121. 121.

    Gloro R Ollivier-Hourmand I Morin-Fatome A Rousselot P Le Moel G Dao T [Disseminated strongyloidiasis associated with pulmonary fibrosis and gastrointestinal bleeding]Gastroenterol Clin Biol2004 281212871290

    Not in our library10.1016/s0399-8320(04)95223-2

  122. 122.

    Hovette P Tuan JF Camara P Lejean Y Lo N Colbacchini P [Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient]Presse Med2002 312210211023

    Not in our library

  123. 123.

    Marsan C Marais MH Sollet JP Le Turdu F Guerin PH Garcia R Bleichner G Disseminated strongyloidiasis: a case reportCytopathology: J British Soc Clin Cytol1993 42123126

    Not in our library10.1111/j.1365-2303.1993.tb00525.x

  124. 124.

    Mattioni S Valin N Cracco C Thellier M Danis M Caumes E Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatmentAnn Trop Med Parasitol2008 1028693698

    Not in our library10.1179/136485908x337616

  125. 125.

    Mejia JH Denis M Leleu G Roux P Mayaud C Akoun G [Acute respiratory insufficiency caused by hyperinfestation with strongyloides. BALF diagnosis and favourable outcome]Rev Pneumol Clin1992 4827578

    Not in our library

  126. 126.

    Pacanowski J Santos MD Roux A LEM C Guillot J Lavarde V Cornet M Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case reportAm J Trop Med Hyg2005 731122124

    Not in our library

  127. 127.

    Pinatelle P De Monbrison F Bedock B [Disseminated strongyloidiasis with parasitemia in a patient under corticosteroid-treatment]Med Mal Infect2009 394267269

    Not in our library10.1016/j.medmal.2008.11.005

  128. 128.

    Quinio D Moalic E Masure O Renault A Le Flohic AM [Pulmonary manifestations of malignant strongyloidiasis]Rev Mal Respir2002 192 Pt1265266

    Not in our library

  129. 129.

    Said S Nevez G Moriniere P Fournier A Raccurt CP [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other]Nephrologie1999 206343346

    Not in our library

  130. 130.

    Hauber HP Galle J Chiodini PL Rupp J Birke R Vollmer E Zabel P Lange C Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectinInfection2005 335–6383386

    Not in our library10.1007/s15010-005-5060-x

  131. 131.

    Steiner B Riebold D Wolff D Freund M Reisinger EC Strongyloides stercoralis eggs in a urethral smear after bone marrow transplantationClin Inf Dis: Inf Dis Soc Am2002 34912801281

    Not in our library10.1086/339753

  132. 132.

    Almasidou D Maniatis M Vassiou K Damani E Vakalis N Fesoulidis I Gourgoulianis KI Strongyloides hyperinfection in a patient with sarcoidosisRespirology2003 81105106

    Not in our library10.1046/j.1440-1843.2003.00429.x

  133. 133.

    Bamias G Toskas A Psychogiou M Delladetsima I Siakavellas SI Dimarogona K Daikos GL Strongyloides hyperinfection syndrome presenting as enterococcal meningitis in a low-endemicity areaVirulence2010 15468470

    Not in our library10.4161/viru.1.5.12703

  134. 134.

    Kosmadakis G Georgoulias C Filiopoulos V Stefanou I Smirloglou D Michail S Lethal Strongyloides stercoralis superinfection in an immunocompromised patientRen Fail2010 326750752

    Not in our library10.3109/0886022x.2010.486490

  135. 135.

    Casati A Cornero G Muttini S Tresoldi M Gallioli G Torri G Hyperacute pneumonitis in a patient with overwhelming Strongyloides stercoralis infectionEur J Anaesthesiol1996 135498501

    Not in our library10.1097/00003643-199609000-00014

  136. 136.

    Gulletta M Chatel G Pavia M Signorini L Tebaldi A Bombana E Carosi G AIDS and strongyloidiasisInt J STD AIDS1998 97427429

    Not in our library10.1258/0956462981922421

  137. 137.

    Mariotta S Pallone G Li Bianchi E Gilardi G Bisetti A Strongyloides stercoralis hyperinfection in a case of idiopathic pulmonary fibrosisPanminerva Med1996 3814547

    Not in our library

  138. 138.

    Pampiglione S Pampiglione E Di Stefano MA [Strongyloides stercoralis hyperinfection with encephalitis manifestations]Pathologica1993 851096195204

    Not in our library

  139. 139.

    Rotolo U Scarlata F Giordano S Tortorici C Bono L Coglitore M Faraci C Infurnari L Rubino R Romano A [Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive2007 1515962

    Not in our library

  140. 140.

    Sidoni A Polidori GA Alberti PF Scionti L Fatal Strongyloides stercoralis hyperinfection diagnosed by Papanicolaou-stained sputum smearsPathologica1994 8618790

    Not in our library

  141. 141.

    Lanzafame M Faggian F Lattuada E Antolini D Vento S Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restorationJ Infect Dis2005 19161027

    Not in our library10.1086/428099

  142. 142.

    Brugemann J Kampinga GA Riezebos-Brilman A Stek CJ Edel JP van der Bij W Sprenger HG Zijlstra F Two donor-related infections in a heart transplant recipient: one common, the other a tropical surpriseJ Heart Lung Transplant: Int Soc Heart Transplant2010 291214331437

    Not in our library10.1016/j.healun.2010.08.002

  143. 143.

    Grijsen M van den Berk G Hoekstra E Terpstra W Veldman S Jansen J Intestinal strongyloidiasis as a presenting symptom of HTLV-1-associated adult T-cell leukemia/lymphomaEndoscopy2009 41Suppl 2E271E272

    Not in our library10.1055/s-0029-1215068

  144. 144.

    Janssen R Vlaminckx BJ Seldenrijk CA Voorn GP Grutters JC Strongyloides stercoralis hyperinfection mimicking accelerated form of idiopathic pulmonary fibrosisLancet Inf Dis2008 87456

    Not in our library10.1016/s1473-3099(08)70155-5

  145. 145.

    Van Hattem S Schuttelaar ML Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpuraClin Exp Dermatol2010 354e149e150

    Not in our library10.1111/j.1365-2230.2009.03740.x

  146. 146.

    Gomez J Plaza V Munoz C Franquet T [Hyperinfection by Strongyloides stercoralis and other pathogens in a patient with chronic obstructive airways disease]Medicina clinica1997 10915609

    Not in our library

  147. 147.

    Llagunes J Mateo E Pena JJ Carmona P De Andres J [Hyperinfection caused by Strongyloides stercoralis]Medicina intensiva/Sociedad Espanola de Medicina Intensiva y Unidades Coronarias2010 345353356

    Not in our library10.1016/j.medin.2009.06.006

  148. 148.

    Lopez Gallardo A Diez Garcia F Yelamos F Orozco F [Hyperinfection by Strongyloides stercoralis in a patient with ulcerative colitis]Enferm Infecc Microbiol Clin1997 155273

    Not in our library

  149. 149.

    Mayayo E Gomez-Aracil V Azua-Blanco J Azua-Romeo J Capilla J Mayayo R Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytologyJ Clin Pathol2005 584420422

    Not in our library10.1136/jcp.2004.017756

  150. 150.

    Rodriguez-Hernandez MJ Ruiz-Perez-Pipaon M Canas E Bernal C Gavilan F Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipientAm J Transplant: J Am Soc Transplant Am Soc Transplant Sur2009 91126372640

    Not in our library10.1111/j.1600-6143.2009.02828.x

  151. 151.

    Rojo-Marcos G Cuadros-Gonzalez J Gonzalez-Juarez MJ Gomez-Ayerbe C [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment]Enferm Infecc Microbiol Clin2009 277432434

    Not in our library10.1016/j.eimc.2008.11.015

  152. 152.

    Sauca Subias G Barrufet Barque P Besa Beringues A Rodriguez Ramos E [Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome]An Med Interna2005 223139141

    Not in our library10.4321/s0212-71992005000300009

  153. 153.

    Tirado MD Gil M Galiano J Pardo F Moreno R Del Busto AG Sabater S Gomila B [Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment]Enferm Infecc Microbiol Clin2002 208401402

    Not in our library

  154. 154.

    Tornero C Galan A Garrigos E Ramos JA Pastor A [Hyperinfection by S. stercoralis: membranous glomerulonephritis, double bacteremia and petechiae exanthema]Enferm Infecc Microbiol Clin1998 1610495496

    Not in our library

  155. 155.

    Troncoso Garcia E Munoz Medina L Callejas Rubio JL Lopez Ruz MA [Klebsiella pneumoniae meningitis, Strongyloides stercoralis infection and HTLV-1]Medicina clinica2000 1154158

    Not in our library10.1016/s0025-7753(00)71493-x

  156. 156.

    Pusztaszeri M Bouzourene H [Intestinal and disseminated strongyloidosis: two case studies]Ann Pathol2005 254322326

    Not in our library10.1016/s0242-6498(05)80137-3

  157. 157.

    Brown M Cartledge JD Miller RF Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapyInt J STD AIDS2006 178560561

    Not in our library10.1258/095646206778145712

  158. 158.

    Chiodini PL Reid AJ Wiselka MJ Firmin R Foweraker J Parenteral ivermectin in Strongyloides hyperinfectionLancet2000 35591974344

    Not in our library10.1016/s0140-6736(99)02744-0

  159. 159.

    Feely NM Waghorn DJ Dexter T Gallen I Chiodini P Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatmentAnaesthesia2010 653298301

    Not in our library10.1111/j.1365-2044.2009.06196.x

  160. 160.

    Gill GV Beeching NJ Khoo S Bailey JW Partridge S Blundell JW Luksza AR A British Second World War veteran with disseminated strongyloidiasisT Roy Soc Trop Med H2004 986382386

    Not in our library10.1016/j.trstmh.2003.11.002

  161. 161.

    Harcourt-Webster JN Scaravilli F Darwish AH Strongyloides stercoralis hyperinfection in an HIV positive patientJ Clin Pathol1991 444346348

    Not in our library10.1136/jcp.44.4.346

  162. 162.

    Orlent H Crawley C Cwynarski K Dina R Apperley J Strongyloidiasis pre and post autologous peripheral blood stem cell transplantationBone Marrow Transplant2003 321115117

    Not in our library10.1038/sj.bmt.1704104

  163. 163.

    Pagliuca A Strongyloides hyperinfection in adult T-cell leukaemia/lymphomaBritish J Haematol1999 10511

    Not in our library10.1111/j.1365-2141.1999.01401.x

  164. 164.

    Rahim S Drabu Y Jarvis K Melville D Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoeaTrans R Soc Trop Med H2005 993215217

    Not in our library10.1016/j.trstmh.2004.08.003

  165. 165.

    Heath T Riminton S Garsia R MacLeod C Systemic strongyloidiasis complicating HIV: a promising response to ivermectinInt J STD AIDS1996 74294296

    Not in our library10.1258/0956462961917843

  166. 166.

    Lim L Biggs BA Fatal disseminated strongyloidiasis in a previously treated patientMed J Australia2001 1747355356

    Not in our library10.5694/j.1326-5377.2001.tb143315.x

  167. 167.

    Mak DB Recurrent bacterial meningitis associated with strongyloides hyperinfectionMed J Australia1993 1595354

    Not in our library10.5694/j.1326-5377.1993.tb137883.x

  168. 168.

    Mak DB Recurrent bacterial meningitis associated with strongyloides hyperinfectionMed J Aust1993 1595354

    Not in our library10.5694/j.1326-5377.1993.tb137883.x

  169. 169.

    Thomas MC Costello SA Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgeryInt J Clin Prac1998 527520521

    Not in our library

  170. 170.

    Kanazawa S Yamaguchi K Kinoshita Y Nomura S Adult T-cell leukaemia and strongyloidiasisEur J Cancer Care (Engl)2008 172209210

    Not in our library10.1111/j.1365-2354.2007.00836.x

  171. 171.

    Kinjo T Tsuhako K Nakazato I Ito E Sato Y Koyanagi Y Iwamasa T Extensive intra-alveolar haemorrhage caused by disseminated strongyloidiasisInt J Parasitol1998 282323330

    Not in our library10.1016/s0020-7519(97)00162-8

  172. 172.

    Miyazaki M Tamura M Kabashima N Serino R Shibata T Miyamoto T Furuno Y Nishio T Ohara J Sakurai T Minimal change nephrotic syndrome in a patient with strongyloidiasisClin Exp Nephrol2010 144367371

    Not in our library10.1007/s10157-010-0273-4

  173. 173.

    Mori S Konishi T Matsuoka K Deguchi M Ohta M Mizuno O Ueno T Okinaka T Nishimura Y Ito N Strongyloidiasis associated with nephrotic syndromeIntern Med1998 377606610

    Not in our library10.2169/internalmedicine.37.606

  174. 174.

    Morimoto J Kaneoka H Sasatomi Y Sato YN Murata T Ogahara S Sakata N Takebayashi S Naito S Saito T Disseminated strongyloidiasis in nephrotic syndromeClin Nephrol2002 575398401

    Not in our library

  175. 175.

    Satoh M Futami A Takahira K Kodaira M Tanaka T Kuriki K Hori E Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral loadJ Infect Chemother2003 94355357

    Not in our library10.1007/s10156-003-0272-4

  176. 176.

    Setoyama M Fukumaru S Takasaki T Yoshida H Kanzaki T SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasisScand J Rheumatol1997 265389391

    Not in our library10.3109/03009749709065706

  177. 177.

    Wong VW Leung WK To KF Sung JJ Diarrhoea and rash in a retired farmerHKMJ, Xianggang yi xue za zhi/Hong Kong Academy of Medicine2005 115397398

    Not in our library

  178. 178.

    Chiu HH Lai SL Fatal meningoencephalitis caused by disseminated strongyloidiasisActa Neurol Taiwan2005 1412427

    Not in our library

  179. 179.

    Hsieh YP Wen YK Chen ML Minimal change nephrotic syndrome in association with strongyloidiasisClin Nephrol2006 666459463

    Not in our library10.5414/cnp66459

  180. 180.

    Huang MS Hwang KP Chiang PC Hwang JJ Pulmonary hyperinfection with Strongyloides stercoralisJ Formos Med Asso, Taiwan yi zhi1996 957551554

    Not in our library

  181. 181.

    Ting YM Pulmonary strongyloidiasis–case report of 2 casesKaohsiung J Med Sci2000 165269274

    Not in our library

  182. 182.

    Liu HC Hsu JY Chang KM Strongyloides stercoralis hyperinfection presenting with symptoms mimicking acute exacerbation of chronic obstructive pulmonary diseaseJCMA2009 728442445

    Not in our library10.1016/s1726-4901(09)70403-4

  183. 183.

    Hira PR Al-Ali F Shweiki HM Abdella NA Johny M Francis I Iqbal J Thompson R Nevar F Strongyloidiasis: challenges in diagnosis and management in non-endemic KuwaitAnn Trop Med Parasitol2004 983261270

    Not in our library10.1179/000349804225003299

  184. 184.

    Mokaddas EM Shati S Abdulla A Nampoori NR Iqbal J Nair PM Said T Abdulhalim M Hira PR Fatal strongyloidiasis in three kidney recipients in KuwaitMed Princ Pract: Int J K U, Health Sci Centre2009 185414417

    Not in our library10.1159/000226298

  185. 185.

    Al Maslamani MA Al Soub HA Al Khal AL Al Bozom IA Abu Khattab MJ Chacko KC Strongyloides stercoralis hyperinfection after corticosteroid therapy: a report of two casesAnn Saudi Med2009 295397401

    Not in our library10.4103/0256-4947.55172

  186. 186.

    Uwaydah AK Al Qadah F Strongyloides stercoralis hyperinfection in a patient with angioimmunoblastic lymphadenopathyPostgrad Med J1992 68806974975

    Not in our library10.1136/pgmj.68.806.974

  187. 187.

    Malnick S Somin M Beilinson N Basevitch A Bregman G Zimhony O Strongyloides hyperinfection in Ethiopian immigrants in IsraelIMAJ2009 1111660663

    Not in our library

  188. 188.

    Somin M Neogolani V Zimhony O Wolpart A Sokolowski N Malnick S Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infectionEur J Int Med2008 196e42e43

    Not in our library10.1016/j.ejim.2007.07.009

  189. 189.

    Kia EB Rahimi HR Mirhendi H Nilforoushan MR Talebi A Zahabiun F Kazemzadeh H Meamar AR A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolateKorean J Parasitol2008 464261263

    Not in our library10.3347/kjp.2008.46.4.261

  190. 190.

    Gulbas Z Kebapci M Pasaoglu O Vardareli E Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophiliaSouth Med J2004 979907910

    Not in our library10.1097/01.smj.0000139936.20116.a7

  191. 191.

    Incani RN Hernandez M Cortez J Gonzalez ME Salazar YD Staphylococcus warneri meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a caseRev Inst Med Trop Sao Paulo2010 523169170

    Not in our library10.1590/s0036-46652010000300011

  192. 192.

    Chaudhary K Smith RJ Himelright IM Baddour LM Case report: purpura in disseminated strongyloidiasisAm J Med Sci1994 3083186191

    Not in our library10.1097/00000441-199409000-00014

  193. 193.

    Davidson RA Infection due to Strongyloides stercoralis in patients with pulmonary diseaseSouth Med J1992 8512831

    Not in our library10.1097/00007611-199201000-00008

  194. 194.

    Kim J Joo HS Ko HM Na MS Hwang SH Im JC A case of fatal hyperinfective strongyloidiasis with discovery of autoinfective filariform larvae in sputumKorean J Parasitol2005 4325155

    Not in our library10.3347/kjp.2005.43.2.51

  195. 195.

    Ochoa MD Ramirez-Mendoza P Ochoa G Vargas MH Alba-Cruz R Rico-Mendez FG [Bronchial nodules produced by Strongyloides stercoralis as the cause of bronchial obstruction]Arch Bronconeumol2003 3911524526

    Not in our library10.1157/13053217

  196. 196.

    Roman-Velez JM Martinez-Camacho RN Alayon-Laguer D Fernandez-Gonzalez R Reyes-Sosa R Santos-Llanos G Colon-Perez M Ferrer D An unusual presentation of alveolar hemorrhagePCRJ: J Gen Prac Airways Group2009 184337339

    Not in our library10.4104/pcrj.2009.00049

  197. 197.

    Arsic-Arsenijevic V Dzamic A Dzamic Z Milobratovic D Tomic D Fatal Strongyloides stercoralis infection in a young woman with lupus glomerulonephritisJ Nephrol2005 186787790

    Not in our library

  198. 198.

    Finkielman JD Grinberg AR Paz LA Plana JL Benchetrit GA Nicastro MA Roncoroni AJ Case report: reactive hemophagocytic syndrome associated with disseminated strongyloidiasisAm J Med Sci1996 31213739

    Not in our library10.1097/00000441-199607000-00008

  199. 199.

    Yun HR Yoo DH Lee HS Kim TH Ahn MH Min DY Park MH Kim SY Fatal strongyloides hyper-infection in a patient with rheumatoid arthritisClin Exp Rheumatol2001 192224

    Not in our library

  200. 200.

    Koh MS Leng PH Eng P Hwang J An unusual cause of pulmonary haemorrhage in a patient with rheumatoid arthritisAnn Acad Med Singap2004 333365367

    Not in our library

  201. 201.

    Leung VK Liew CT Sung JJ Fatal strongyloidiasis in a patient with ulcerative colitis after corticosteroid therapyAm J Gastroenterol1997 92813831384

    Not in our library

  202. 202.

    Shorman M Al-Tawfiq JA Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytomaIJID: Int Soc Inf Dis2009 135e288e291

    Not in our library10.1016/j.ijid.2008.11.019

  203. 203.

    Fasih N Irfan S Sheikh U Beg MS A fatal case of gram negative bacterial sepsis associated with disseminated strongyloidiasis in an immunocompromised patientJPMA2008 5829192

    Not in our library

  204. 204.

    Seet RC Lau LG Tambyah PA Strongyloides hyperinfection and hypogammaglobulinemiaClin Diagn Lab Immunol2005 125680682

    Not in our library10.1128/cdli.12.5.680-682.2005

  205. 205.

    Czachor JS Jonas AP Transmission of Strongyloides steracolis person to personJ Travel Med2000 74211212

    Not in our library10.2310/7060.2000.00063

  206. 206.

    Csermely L Jaafar H Kristensen J Castella A Gorka W Chebli AA Trab F Alizadeh H Hunyady B Strongyloides hyper-infection causing life-threatening gastrointestinal bleedingWJG2006 123964016404

    Not in our library10.3748/wjg.v12.i39.6401

  207. 207.

    Azira NM Zeehaida M Strongyloides stercoralis hyperinfection in a diabetic patient: case reportTrop Biomed2010 271115119

    Not in our library

  208. 208.

    Vithayasai N Jennuvat S Gastrointestinal manifestations in severe strongyloidiasis: report of 3 cases and literature reviewSoutheast Asian J Trop Med Public Health2010 4112227

    Not in our library

  209. 209.

    Pornsuriyasak P Niticharoenpong K Sakapibunnan A Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasisSoutheast Asian J Trop Med Public Health2004 353531534

    Not in our library

  210. 210.

    Suvajdzic N Kranjcic-Zec I Jovanovic V Popovic D Colovic M Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopeniaHaematologia1999 294323326

    Not in our library

  211. 211.

    Hagelskjaer LH A fatal case of systemic strongyloidiasis and review of the literatureEur J Clin Microbiol Infect Dis: Eur Soc Clin Microbiol1994 131210691074

    Not in our library10.1007/bf02111831

  212. 212.

    Leang B Lynen L Tootill R Griffiths S Monchy D Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reactionLepr Rev2004 754398403

    Not in our library

  213. 213.

    Wong TY Szeto CC Lai FF Mak CK Li PK Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agentsNephron1998 793333336

    Not in our library10.1159/000045058

  214. 214.

    Adedayo AO Grell GA Bellot P Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infectionAm J Trop Med Hyg2001 655650651

    Not in our library10.4269/ajtmh.2001.65.650

  215. 215.

    Foucan L Genevier I Lamaury I Strobel M [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis]Med Trop (Mars)1997 573262264

    Not in our library

  216. 216.

    N’Dri K Kouame KE Sahari R Hommel D Hulin A [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection]Med Mal Infect2008 383162164

    Not in our library10.1016/j.medmal.2007.11.012

  217. 217.

    Drug V Haliga R Akbar Q Mihai C Cijevschi Prelipcean C Stanciu C Ascites with Strongyloides stercoralis in a patient with acute alcoholic pancreatitis and liver cirrhosisJGLD2009 183367369

    Not in our library

  218. 218.

    Ho PL Luk WK Chan AC Yuen KY Two cases of fatal strongyloidiasis in Hong KongPathology1997 293324326

    Not in our library10.1080/00313029700169215

  219. 219.

    WHOModel Lists of Essential Medicineshttp://www.who.int/medicines/publications/essentialmedicines/en/

    Not in our library

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.